HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Inaba Selected Research

Bone Resorption

2/2013Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
7/2012Serum adiponectin and bone mineral density in male hemodialysis patients.
3/2011Reduction of whole PTH/intact PTH ratio as a predictor of bone metabolism in cinacalcet treatment of hemodialysis patients with secondary hyperparathyroidism.
8/2001Clinical evaluation of the Elecsys beta-CrossLaps serum assay, a new assay for degradation products of type I collagen C-tlopeptides.
11/2000Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Inaba Research Topics

Disease

8Type 2 Diabetes Mellitus (MODY)
04/2017 - 09/2000
7Neoplasms (Cancer)
07/2006 - 01/2000
6Chronic Renal Insufficiency
01/2019 - 07/2012
6Diabetes Mellitus
11/2013 - 01/2000
5Hypertension (High Blood Pressure)
05/2014 - 01/2000
5Bone Resorption
02/2013 - 11/2000
5Autoimmune Diseases (Autoimmune Disease)
04/2008 - 03/2000
4Breast Neoplasms (Breast Cancer)
07/2006 - 01/2000
4Atherosclerosis
10/2003 - 10/2001
4Chronic Kidney Failure (Chronic Renal Failure)
10/2001 - 08/2001
3Renal Insufficiency (Renal Failure)
01/2019 - 11/2000
3Bone Diseases (Bone Disease)
01/2018 - 10/2001
3Secondary Hyperparathyroidism
01/2018 - 03/2011
3Rheumatoid Arthritis
01/2008 - 03/2000
3Vascular Calcification
10/2007 - 10/2002
3Neoplasm Metastasis (Metastasis)
11/2001 - 01/2000
2Osteoporosis
01/2019 - 01/2001
2Malnutrition (Nutritional Deficiencies)
10/2010 - 10/2001
2Vascular System Injuries
07/2002 - 02/2001
2Hyperthyroidism
07/2002 - 02/2001
2Carcinogenesis
08/2001 - 11/2000
2Hyperparathyroidism
08/2001 - 06/2000
2Leukemia
07/2001 - 11/2000
2Insulin Resistance
03/2001 - 01/2000
2Graves Disease (Basedow Disease)
02/2001 - 11/2000
2Thrombocytopenia (Thrombopenia)
02/2001 - 03/2000
2Hypercalcemia (Milk Alkali Syndrome)
06/2000 - 01/2000
1Hypocalcemia
01/2019
1Infections
04/2018
1Cerebral Cortical Thinning
01/2018
1Hypoglycemia (Reactive Hypoglycemia)
04/2017
1Cicatrix (Scar)
01/2017
1Vitamin K Deficiency
03/2015
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
05/2014
1Neurologic Manifestations (Neurological Manifestations)
05/2014
1Body Weight (Weight, Body)
07/2012
1Anuria
10/2010
1Carotid Artery Diseases
10/2003

Drug/Important Bio-Agent (IBA)

8Parathyroid Hormone (Parathormone)IBA
01/2015 - 06/2000
5CalciumIBA
01/2019 - 06/2000
4DNA (Deoxyribonucleic Acid)IBA
04/2018 - 03/2000
4CreatinineIBA
10/2010 - 09/2000
3Cinacalcet (Sensipar)FDA Link
01/2018 - 03/2011
3OsteocalcinIBA
03/2015 - 06/2000
3Phosphates (Orthophosphate)IBA
11/2013 - 10/2002
3Glucose (Dextrose)FDA LinkGeneric
02/2013 - 01/2000
3Alkaline PhosphataseIBA
02/2013 - 11/2000
3Proteins (Proteins, Gene)FDA Link
07/2006 - 06/2000
3Antithyroid Agents (Antithyroid Drugs)IBA
07/2002 - 11/2000
3LipidsIBA
10/2001 - 06/2000
2Serum AlbuminIBA
11/2013 - 08/2000
2CytokinesIBA
01/2008 - 01/2000
2Insulin (Novolin)FDA Link
12/2007 - 01/2000
2LDL CholesterolIBA
10/2003 - 10/2001
2HDL LipoproteinsIBA
10/2003 - 10/2001
2Retinaldehyde (Retinal)IBA
07/2002 - 02/2001
2Lipoproteins (Lipoprotein)IBA
10/2001 - 06/2001
2HomocysteineIBA
10/2001 - 03/2001
2Immunosuppressive Agents (Immunosuppressants)IBA
05/2001 - 03/2000
2AntibodiesIBA
02/2001 - 04/2000
2Fluorouracil (Carac)FDA LinkGeneric
01/2001 - 11/2000
1DenosumabFDA Link
01/2019
1Bone Density Conservation AgentsIBA
01/2019
1Genetic Markers (Genetic Marker)IBA
04/2018
1Ion Channels (Ion Channel)IBA
04/2018
1alfacalcidolIBA
01/2018
1maxacalcitolIBA
01/2018
1Hypoglycemic Agents (Hypoglycemics)IBA
04/2017
1repaglinide (Prandin)FDA Link
04/2017
1AngiotensinogenIBA
07/2014
1Biomarkers (Surrogate Marker)IBA
07/2014
1Superoxide Dismutase-1IBA
05/2014
1Amino Acid Transport System X-AG (Glutamate Transporter)IBA
05/2014
1Excitatory Amino AcidsIBA
05/2014
1C-Reactive ProteinIBA
11/2013
1Tartrate-Resistant Acid PhosphataseIBA
02/2013
1tartaric acid (tartrate)FDA Link
02/2013
1AcidsIBA
02/2013
1AdiponectinIBA
07/2012
1collagen type I trimeric cross-linked peptideIBA
07/2012
1Collagen Type I (Type I Collagen)IBA
07/2012
1MineralsIBA
07/2012
1Calcium-Sensing ReceptorsIBA
10/2011
1Mitogen-Activated Protein KinasesIBA
01/2008
1Streptozocin (Streptozotocin)FDA Link
12/2007
1calcium phosphateIBA
10/2007
1MagnesiumIBA
10/2007
1Fibroblast Growth Factor-23IBA
10/2006
1Cadherins (E-Cadherin)IBA
07/2006
1HDL CholesterolIBA
10/2003

Therapy/Procedure

15Renal Dialysis (Hemodialysis)
01/2018 - 11/2000
8Bone Marrow Transplantation (Transplantation, Bone Marrow)
04/2008 - 03/2000
6Therapeutics
12/2007 - 02/2001
4Glycemic Control
04/2017 - 10/2003
3Transplantation
03/2007 - 01/2000
2Oral Administration
11/2001 - 01/2001
1Prostheses and Implants (Prosthesis)
01/2017
1Laparotomy
01/2017
1Ligation
01/2017
1Islets of Langerhans Transplantation
12/2007